Using Intravenous Immunoglobulin (IVIG) to Treat Patients with Primary Immune Deficiency Disease
- 28 December 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Clinical Immunology
- Vol. 33 (2), 90-94
- https://doi.org/10.1007/s10875-012-9838-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Longitudinal decline in lung function in patients with primary immunoglobulin deficienciesJournal of Allergy and Clinical Immunology, 2011
- Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studiesClinical Immunology, 2010
- Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyClinical Immunology, 2010
- Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 yearsJournal of Allergy and Clinical Immunology, 2010
- History of Immunoglobulin ReplacementImmunology and Allergy Clinics of North America, 2008
- Immunoglobulin Replacement Therapy in ChildrenImmunology and Allergy Clinics of North America, 2008
- Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infectionJournal of Allergy and Clinical Immunology, 2008
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006
- Intravenous Immunoglobulin: Adverse Effects and Safe AdministrationClinical Reviews in Allergy & Immunology, 2005
- Primary cellular immunodeficienciesJournal of Allergy and Clinical Immunology, 2002